Finance

Lists
CLBIO:STO
Corline Biomedical AB
SEK 14.35
-1.03%
(-0.15) 1D
Sep 29, 5:29:38 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CLBIO...
Open
SEK 15.00
High
SEK 15.00
Low
SEK 13.80
Mkt. cap
375.01M
Avg. vol.
12.08K
Volume
6.82K
52-wk high
SEK 27.20
52-wk low
SEK 13.15
EPS
-SEK 0.49
Shares outstanding
26.13M
No. of employees
14
Open
SEK 15.00
High
SEK 15.00
Low
SEK 13.80
Mkt. cap
375.01M
Avg. vol.
12.08K
Volume
6.82K
52-wk high
SEK 27.20
52-wk low
SEK 13.15
EPS
-SEK 0.49
Shares outstanding
26.13M
No. of employees
14
About Corline Biomedical AB
CEOHenrik Nittmar
Employees14
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitecorline.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.30M
2.10M
4.29M
4.75M
Cost of goods sold
631.00K
716.00K
-79.00K
139.00K
Cost of revenue
631.00K
716.00K
-79.00K
139.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.07M
6.47M
6.79M
6.00M
Operating expense
4.04M
6.46M
6.87M
6.04M
Total operating expenses
4.67M
7.17M
6.80M
6.18M
Operating income
-3.37M
-5.07M
-2.50M
-1.43M
Other non operating income
9.00K
-30.00K
2.00K
-4.00K
EBT including unusual items
-3.36M
-5.03M
-2.50M
-1.44M
EBT excluding unusual items
-3.36M
-5.03M
-2.50M
-1.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-44.00K
-30.00K
61.00K
4.00K
Net income
-3.36M
-5.03M
-2.50M
-1.44M
Net profit margin
-257.39%
-238.93%
-58.28%
-30.20%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
38.00K
1.00K
-
Interest expense
-1.00K
-
-
-
Net interest expenses
-
38.00K
1.00K
-
Depreciation and amortization charges
12.00K
20.00K
20.00K
36.00K
EBITDA
-3.36M
-5.03M
-2.48M
-1.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps